Core Viewpoint - A class action lawsuit has been filed against UnitedHealth Group Incorporated for alleged violations of federal securities laws during the class period from December 3, 2024, to April 16, 2025 [2][3] Group 1: Allegations Against UnitedHealth - The lawsuit claims that UnitedHealth engaged in a corporate strategy of denying health coverage to increase profits and share price [3] - It is alleged that this strategy led to regulatory scrutiny and public outrage, culminating in the murder of an individual named Brian Thompson [3] - Following the murder, there was significant public animosity towards UnitedHealth, with some individuals expressing admiration for the accused killer [3] - The company reportedly changed its corporate practices in response to the regulatory and public backlash [3] - Despite these changes, UnitedHealth continued to issue guidance that was deemed unrealistic given the evolving corporate strategies [3] Group 2: Legal Process and Participation - Investors who suffered losses in UnitedHealth have until July 7, 2025, to request to be appointed as lead plaintiff in the class action [4] - Participation in any recovery does not require serving as lead plaintiff [4] - The law firm representing the investors operates on a contingency fee basis, meaning they will only collect fees if the case is successful [5] Group 3: Law Firm Background - Bronstein, Gewirtz & Grossman, LLC is a nationally recognized law firm specializing in securities fraud class actions and has recovered hundreds of millions of dollars for investors [6]
UNH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that UnitedHealth Group Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit